Santen Pharmaceutical Co., Ltd.
Status: Publicly traded
Direct answer
Santen Pharmaceutical Co., Ltd. is publicly traded on JPX under the ticker 4536.T.
Santen Pharmaceutical Co., Ltd. is a global enterprise engaged in the research, development, manufacturing, and marketing of both pharmaceutical products and medical devices. The company's primary focus lies in ophthalmic solutions, addressing a variety of eye conditions. Its pipeline for glaucoma and ocular hypertension includes several key assets: DE-111, currently in Phase III clinical trials; DE-117, available...
Can you invest in Santen Pharmaceutical Co., Ltd.?
Yes. Santen Pharmaceutical Co., Ltd. trades publicly on JPX as 4536.T.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Santen Pharmaceutical Co., Ltd.
Detailed equity research is provided by MarketSnap.